Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Smith Lillian — Allogene Therapeutics, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Smith Lillian

Smith Lillian

VP, Corporate Counsel at Allogene Therapeutics, Inc. · on record since Apr 5, 2023

Insider trading activity of Smith Lillian

Transactions on record: 1; since Apr 5, 2023

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Apr 5, 2023

Figures computed from official regulatory filings — methodology.

Companies where Smith Lillian has traded

Allogene Therapeutics, Inc.1 tx · Apr 5, 2023

Track record of Smith Lillian

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Smith Lillian

Co-insiders of Smith Lillian

Amado RafaelAllogene Therapeutics, Inc.
Barrett Elizabeth A.Allogene Therapeutics, Inc.
Belldegrun ArieAllogene Therapeutics, Inc.
Beneski Benjamin MachinasAllogene Therapeutics, Inc.
Bhavnagri VeerAllogene Therapeutics, Inc.
BONDERMAN DAVIDAllogene Therapeutics, Inc.
Chang David DAllogene Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

CHEN YINLIN JACKAllogene Therapeutics, Inc.

COULTER JAMES GAllogene Therapeutics, Inc.

DEYOUNG JOHN A.Allogene Therapeutics, Inc.

Douglas Earl MartinAllogene Therapeutics, Inc.

Humer Franz BAllogene Therapeutics, Inc.

KAZAM JOSHOA AAllogene Therapeutics, Inc.

Mayo StephenAllogene Therapeutics, Inc.

MESSEMER DEBORAH M.Allogene Therapeutics, Inc.

MOORE ALISONAllogene Therapeutics, Inc.

MOORE TIMOTHY L.Allogene Therapeutics, Inc.

Parker Geoffrey M.Allogene Therapeutics, Inc.

PF Equity Holdings 2 B.V.Allogene Therapeutics, Inc.

PFIZER INCAllogene Therapeutics, Inc.

Roberts ZacharyAllogene Therapeutics, Inc.

SATO VICKI LAllogene Therapeutics, Inc.

SCHMIDT ERIC THOMASAllogene Therapeutics, Inc.

Sisitsky Todd BenjaminAllogene Therapeutics, Inc.

TPG GP A, LLCAllogene Therapeutics, Inc.

TPG Group Holdings (SBS) Advisors, Inc.Allogene Therapeutics, Inc.

WINKELRIED JONAllogene Therapeutics, Inc.

WITTE OWEN N.Allogene Therapeutics, Inc.

Yoshiyama AnnieAllogene Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Allogene Therapeutics, Inc.	Apr 5, 2023	Award	56,545	0.00 USD	$0	SEC